Anika Therapeutics, an orthopedic medicines company, is paying $95 million up front for two privately held firms that make joint replacement products as it seeks to broaden its pipeline.
Anika — which may be unfamiliar to most people but has a market value of more than three quarters of a billion dollars — said Monday that it was buying Arthrosurface of Franklin, Mass., for $60 million and Parcus Medical of Sarasota, Fla., for $35 million.
